Scientists Discover Hidden Compounds in Cannabis That Nobody Expected to Find
Researchers uncover 79 phenolic compounds in cannabis leaves, including rare flavoalkaloids never seen before in the plant.
Blog
AI is Automating Opinion Polls. That Should Worry Us.
French startup Naratis is replacing human pollsters with AI. It's faster and cheaper—but at what cost to trust?
Leakproof Underwear Isn't Just for Periods Anymore
Why bladder leaks don't have to mean switching to adult diapers. One brand's innovation is changing the conversation around incontinence.
Apple's AI Bet and the Memory Crisis: What's Really Going On Behind Cook's Exit
Apple beats expectations but faces a serious memory shortage. Tim Cook's departure signals a shift in how the company tackles AI.
How Big Should Your TV Actually Be? The Math (and Reality) Behind Screen Size
Stop guessing. Here's the science behind picking the right TV size for your room, plus why bigger might be better than you think.
The $25 Billion Price Tag of Escalating Iran Tensions
A quarter-century of conflict costs reveals ripple effects across weapons, energy markets, and global stability.
Busta Rhymes Settles Assault Lawsuit With Former Assistant
Grammy-nominated rapper reaches private settlement in case involving workplace assault allegations and industry blacklisting claims.
Streamer Hit by Car Live on Stream: How Digital Footage Became Evidence
A Twitch streamer's 3,000-mile charity walk took a dangerous turn when a car struck him on camera. Here's what happened next.
Aerobic Exercise Beats All Other Workouts for Knee Arthritis, Major Study Shows
A comprehensive BMJ analysis of 217 trials reveals walking, cycling, and swimming deliver the best results for knee osteoarthritis pain and mobility.
The Week's Reality Check: When Wars Get Expensive and Homework Gets Easier
Pentagon spending hits $25B in Iran war while schools dial back math homework. A look at what's actually happening.
Eli Lilly's Weight Loss Drug Boom Just Got Bigger (And Pricier for Competitors)
Eli Lilly crushes Q1 expectations on Zepbound and Mounjaro demand, raises full-year guidance by $2B, and tightens its grip on the GLP-1 market.
Meta Ends Sama Contract After Workers Expose AI Glasses Privacy Nightmare
Meta cancelled its AI training deal with Sama after workers revealed they reviewed graphic content from smart glasses. Was it standards, or silencing?
